Journal of Environmental Treatment Techniques
0202, Volume 8, Issue 2, Pages: 610-620
1
1
2. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of
amantadine-resistant influenza a virus quasi species after cessation
of antiviral therapy in an immunocompromised patient. Clinical
Infectious Diseases. 2002;34(5):e23-e5.
3. Степанова ЛА, Ковалева А, Потапчук М, Коротков А,
Куприянов В, Блохина Е, et al. Иммуногенные свойства
рекомбинантных белков, включающих эктодомен белка М2
вируса гриппа а. Вопросы вирусологии. 2013;58(3).
Prevention. Hospitalized patients with novel influenza A (H1N1)
virus infection--California. 2009:732-6.
34. Chu H, Lofgren ET, Halloran ME, Kuan PF, Hudgens M, Cole SR.
Performance of rapid influenza H1N1 diagnostic tests: a meta‐
analysis. Influenza and other respiratory viruses. 2012;6(2):80-6.
35. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy
of rapid influenza diagnostic tests: a meta-analysis. Annals of
internal medicine. 2012;156(7):500-11.
1
1
4. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M.
Transmission of influenza A in human beings. The Lancet
infectious diseases. 2007;7(4):257-65.
5. Mousavi SM, Hashemi SA, Zarei M, Bahrani S, Savardashtaki A,
Esmaeili H, et al. Data on cytotoxic and antibacterial activity of
synthesized Fe3O4 nanoparticles using Malva sylvestris. Data in
brief. 2020;28:104929.
36. Karthik L, Kumar G, Keswani T, Bhattacharyya A, Chandar SS,
Rao KB. Protease inhibitors from marine actinobacteria as a
potential source for antimalarial compound. PloS one. 2014;9(3).
37. Nagase H, Moriwaki K, Kamae M, Yanagisawa S, Kamae I. Cost-
effectiveness analysis of oseltamivir for influenza treatment
considering the virus emerging resistant to the drug in Japan. Value
in Health. 2009;12:S62-S5.
1
6. Choi W-S, Lee J, Lee H-Y, Baek J-H, Kim Y-K, Kee S-Y, et al.
Clinical Practice Guideline for Antiviral Treatment and
38. Nshimyumukiza L, Douville X, Fournier D, Duplantie J, Daher
RK, Charlebois I, et al. Cost‐effectiveness analysis of antiviral
treatment in the management of seasonal influenza A: point‐of‐
care rapid test versus clinical judgment. Influenza and other
respiratory viruses. 2016;10(2):113-21.
Chemoprophylaxis of Seasonal Influenza. Infection
Chemotherapy. 2012;44(4).
&
1
1
1
7. Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J,
et al. Aerosol transmission is an important mode of influenza A
virus spread. Nature communications. 2013;4:1935.
8. Wong BC, Lee N, Li Y, Chan PK, Qiu H, Luo Z, et al. Possible
role of aerosol transmission in a hospital outbreak of influenza.
Clinical infectious diseases. 2010;51(10):1176-83.
9. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S,
Leach S, et al. Time lines of infection and disease in human
influenza: a review of volunteer challenge studies. American
journal of epidemiology. 2008;167(7):775-85.
0. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of
multidrug-resistant influenza A virus in an immunocompromised
patient. New England Journal of Medicine. 2003;348(9):867-8.
1. Liu W, Peng L, Liu H, Hua S. Pulmonary function and clinical
manifestations of patients infected with mild influenza A virus
subtype H1N1: a one-year follow-up. PloS one. 2015;10(7).
2. Rello J, Pop-Vicas A. Clinical review: primary influenza viral
pneumonia. Critical Care. 2009;13(6):235.
39. Klugman K. Clinical Microbiology Reviews. Clin Microbiol Rev.
1990;3(2):171-96.
40. Teo J, Di Pietro P, San Biagio F, Capozzoli M, Deng Y-M, Barr I,
et al. VereFlu™: an integrated multiplex RT-PCR and microarray
assay for rapid detection and identification of human influenza A
and B viruses using lab-on-chip technology. Archives of virology.
2011;156(8):1371.
41. Tang Y-W, Lowery KS, Valsamakis A, Schaefer VC, Chappell JD,
White-Abell J, et al. Clinical accuracy of a PLEX-ID flu device for
simultaneous detection and identification of influenza viruses A
and B. Journal of clinical microbiology. 2013;51(1):40-5.
42. Loeffelholz M, Pong D, Pyles R, Xiong Y, Miller A, Bufton K, et
al. Comparison of the FilmArray Respiratory Panel and Prodesse
real-time PCR assays for detection of respiratory pathogens.
Journal of clinical microbiology. 2011;49(12):4083-8.
43. Gholami A, Shahin S, Mohkam M, Nezafat N, Ghasemi Y.
Cloning, characterization and bioinformatics analysis of novel
cytosine deaminase from Escherichia coli AGH09. International
Journal of Peptide Research and Therapeutics. 2015;21(3):365-74.
44. Moghadami M. A narrative review of influenza: a seasonal and
pandemic disease. Iranian journal of medical sciences.
2017;42(1):2.
2
2
2
2
3. Minodier L, Charrel RN, Ceccaldi P-E, Van Der Werf S, Blanchon
T, Hanslik T, et al. Prevalence of gastrointestinal symptoms in
patients with influenza, clinical significance, and pathophysiology
of human influenza viruses in faecal samples: what do we know?
Virology journal. 2015;12(1):215.
2
2
4. Vickers NJ. Animal Communication: When I’m Calling You, Will
You Answer Too? Current Biology. 2017;27(14):R713-R5.
5. Mancinelli L, Onori M, Concato C, Sorge R, Chiavelli S, Coltella
L, et al. Clinical features of children hospitalized with influenza A
and B infections during the 2012–2013 influenza season in Italy.
BMC infectious diseases. 2015;16(1):6.
6. Bahrani S, Hashemi SA, Mousavi SM, Azhdari R. Zinc-based
metal–organic frameworks as nontoxic and biodegradable
platforms for biomedical applications: review study. Drug
metabolism reviews. 2019;51(3):356-77.
7. Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A,
et al. the H1N1 SEMICYUC working group: Intensive care
patients with severe novel H1N1 influenza viral pneumonia in
Spain. Crit Care. 2009;13:R148.
8. To K, Hung I, Li I, Lee K, Koo C, Yan W, et al. Pandemic H1N1
Study Group: Delayed clearance of viral load and marked cytokine
activation in severe cases of pandemic H1N1 2009 influenza virus
infection. Clin Infect Dis. 2010;50:850-9.
45. Behrens G, Stoll M, Kamps B, Hoffman C, Preisser W.
Pathogenesis and immunology. Monografía en Internet] Flying
Publisher Cologne, Holland. 2006;19.
46. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin
Y, et al. Recognition of haemagglutinins on virus-infected cells by
NKp46 activates lysis by human NK cells. Nature.
2001;409(6823):1055-60.
47. Mousavi SM, Zarei M, Hashemi SA, Babapoor A, Amani AM. A
conceptual review of rhodanine: current applications of antiviral
drugs, anticancer and antimicrobial activities. Artificial cells,
nanomedicine, and biotechnology. 2019;47(1):1132-48.
48. García-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE,
Durbin JE, et al. Influenza A virus lacking the NS1 gene replicates
in interferon-deficient systems. Virology. 1998;252(2):324-30.
49. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A,
Swayne DE, et al. Characterization of the reconstructed 1918
Spanish influenza pandemic virus. science. 2005;310(5745):77-80.
50. Abbaszadegan A, Dadolahi S, Gholami A, Moein MR, Hamedani
S, Ghasemi Y, et al. Antimicrobial and cytotoxic activity of
Cinnamomum zeylanicum, Calcium Hydroxide, and triple
antibiotic paste as root canal dressing materials. The journal of
contemporary dental practice. 2016;17(2):105-13.
51. Gholami A, Rasoul-Amini S, Ebrahiminezhad A, Abootalebi N,
Niroumand U, Ebrahimi N, et al. Magnetic properties and
antimicrobial effect of amino and lipoamino acid coated iron oxide
nanoparticles. Minerva Biotecnologica. 2016;28(4):177-86.
52. Mousavi SM, Soroshnia S, Hashemi SA, Babapoor A, Ghasemi Y,
Savardashtaki A, et al. Graphene nano-ribbon based high potential
and efficiency for DNA, cancer therapy and drug delivery
applications. Drug metabolism reviews. 2019;51(1):91-104.
53. Abbaszadegan A, Gholami A, Abbaszadegan S, Aleyasin ZS,
Ghahramani Y, Dorostkar S, et al. The effects of different ionic
liquid coatings and the length of alkyl chain on antimicrobial and
2
2
2
2
3
3
9. Schwarzmann SW, Adler JL, Sullivan RJ, Marine WM. Bacterial
pneumonia during the Hong Kong influenza epidemic of 1968-
1
969: experience in a city-county hospital. Archives of internal
medicine. 1971;127(6):1037-41.
0. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim
G, et al. Staphylococcus aureus community-acquired pneumonia
during the 2006 to 2007 influenza season. Annals of emergency
medicine. 2009;53(3):358-65.
1. Ison MG, Campbell V, Rembold C, Dent J, Hayden FG. Cardiac
findings during uncomplicated acute influenza in ambulatory
adults. Clinical infectious diseases. 2005;40(3):415-22.
2. Foulkes W, Rees J, Sewry C. Influenza A and rhabdomyolysis.
Journal of Infection. 1990;21(3):303-4.
3
3
3. Chen K-F, Gaydos C, Rothman RE. Update on emerging
infections: news from the Centers for Disease Control and
0
1ꢆ